-transparent.png){kind=logo}
Treatment of BALB/c mice with poly(A):poly(U) 18 h prior to infection with a lethal dose of murine cytomegalovirus (MCMV) increased survival. In parallel with increased survival, a 10- to 100-fold reduction of plaque-forming MCMV was found in the liver and spleen of mice 4 days post-infection with a sublethal dose of MCMV. Poly(A):poly(U) did not significantly increase natural killer cell activity or prolong the duration of elevated cytotoxic activity in infected animals. The possible role of interferon in the poly(A):poly(U)-induced protection of BALB/c mice is discussed.
Related Publications
A Adams, and
M Mohrman, and
A G Johnson, and
A Morin, and
E Deschamps de Paillette
June 2014,
Virology journal,
A Adams, and
M Mohrman, and
A G Johnson, and
A Morin, and
E Deschamps de Paillette
March 1991,
The Tokai journal of experimental and clinical medicine,
A Adams, and
M Mohrman, and
A G Johnson, and
A Morin, and
E Deschamps de Paillette
May 2014,
Environmental toxicology and pharmacology,
A Adams, and
M Mohrman, and
A G Johnson, and
A Morin, and
E Deschamps de Paillette
January 2017,
Frontiers in immunology,
A Adams, and
M Mohrman, and
A G Johnson, and
A Morin, and
E Deschamps de Paillette
May 1994,
The Journal of infectious diseases,
A Adams, and
M Mohrman, and
A G Johnson, and
A Morin, and
E Deschamps de Paillette
March 1984,
Biochemical and biophysical research communications,
A Adams, and
M Mohrman, and
A G Johnson, and
A Morin, and
E Deschamps de Paillette
January 2010,
Molecular immunology,
A Adams, and
M Mohrman, and
A G Johnson, and
A Morin, and
E Deschamps de Paillette
April 2015,
Vaccine,
A Adams, and
M Mohrman, and
A G Johnson, and
A Morin, and
E Deschamps de Paillette
November 1996,
Journal of virology,
A Adams, and
M Mohrman, and
A G Johnson, and
A Morin, and
E Deschamps de Paillette
October 1986,
The Tokai journal of experimental and clinical medicine,
